Nevertheless, the fact that losartan treatment attenuated the reduction in the relative muscle weight in females suggests that suppressing the AT1 receptor is an effective strategy against disuse-induced skeletal muscle atrophy in female rats by preventing Smad2/3 signaling. This evidence concerns the gene SMAD2 and muscular atrophy.